To evaluate bone turnover changes occurring during proteinenergy malnutrition, serum osteocalcin, a marker of bone formation, has been studied in healthy control, stunted, and severely malnourished (kwashiorkor and marasmus) Senegalese children. Serum osteocalcin levels were dramatically reduced in stunted, kwashiorkor, and marasmic childrencompared with control children. In addition serum osteocalcin levels of control children living in Senegal were lower (-46%) than those of African children living in France. Interestingly, serum osteocalcin level was not related to its major known regulator s (la,25-dihydroxycholecalciferol, 25-hydroxycholecalciferol, and PTH) nor to stunting,but was related to serum transthyretin and thyroid hormones concentrations. These data suggest that serum osteocalcin level is related to protein-energy status and that bone formation was affected in apparently healthy and in malnourished PEM is a great probl em which concerns about half the world' s children. However, contrary to other aspects of PEM , bone metabolism has received little attention. Most of the studies on bone are from the last decades and were hindered by the lack of appropriate tools for investigation of bone turno ver. Previous studies based on radiography or ash weights have suggested an increase of bone resorption (1), whereas recently, Branca et al. (2), using urinary pyridinoline and deox ypyridinoline concentrations, have dem onstrated that bone resorption is decre ased in PEM. Thanks to the availability of new specific biochemical mark ers, such as osteocalcin, it was found relevant to reevalute with more insight the other side of bone turnover, i.e. bone formation.
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Osteocalcin is the most abundant noncollagenous bone protein and is produced by osteoblast (3). Most of the newly synthesized osteocalcin remains bound to bone hydroxyapatite, but a small fraction of the protein is released into the blood (3, 4) and serum osteocalcin appears to be an useful marker of bon e formation (4). To further clarify possibl e effects of PEM on bone form ation , serum osteocalcin concentrations were determi ned in groups of children from Senegal (West Africa) with various forms of malnutrition in relation to mark ers of the protein energy and the inflammation status. In addition, the main regulators of osteocalcin synthesis, i.e. 1,25(OH)2D and parath yroid and thyroid hormones, were measured to investigate the regulation of serum osteocalcin concentration in PEM .
METHODS
Our criteria for inclusion in the study were based on age and anthropometric and clinic al paramete rs. Bec ause a seasonal rhythm was reported for the serum osteocalcin level (4), the duration of our study in the field did not exceed 1 mo. Fifty-two Seneg alese children nine to 24 mo old were included in the study and classified according their clinical symptoms and their height-for-age in a Z score, which repre sents the distan ce of a value above or below the median of NCHS-FELS growth charts (5), expre ssed in SD units adjusted for age and sex: seven K and 14 M child ren, two severe forms of PEM , hospitalized in Dakar (Senegal) for nutritional rehabilitation; 607 31 children attending the materna l and child health care center in Dakar were then divided into three groups , five SS with height -for-age < -2 Z score, nine MS with height-for-age comprised betwe en -1 and -2 Z score, and 17 CD with height-for-age > -1 Z score . In addition, eight healthy agematched black African children, born and living in Paris (France) with height-for-age > -1 Z score , were included in the study as a further CPoAll children of the CP group received cholecalciferol supplementation of 0.3 mg/d before the age of 10 mo and 5 mg/4 mo between 10 and 24 mo. Thus, we have constituted six groups of children (CP, CD, MS, SS, M, and K), and their anthropometric data are summarized in Table 1 . The hospital Le Dantec (Dak ar, Senegal) did not have a special ethics committee, but the protoco l of the study was approve d by the authorities of the hospital, and ethical aspects of this study were in accordance with the letter and the spirit of the Helsinki Declaration II.
Blood samples were withdrawn from the nonfasting children between 0900 and 1200 h on admission to the hospital before any treatment was started . Blood sample s were allowed to clot on ice about 1 h and then centrifuged at 4°C, and the resulting serum was aliquoted and stored at -20°C before analysis. Special attention was given to the temperature during blood collection in the hospital and transfer of the samples from Dakar to Paris (5 h by plane). All of the assays were performed during the month after the end of the field work, and all hemolyzed samples were excluded from the assays. Serum osteocalcin was determined by RIA (6) using an RIA kit (ORIS-CIS , Gif-sur -Yvette , France) . The coefficients of variations within assay and between assays were, respectively , 3.0 and 5.5 %. The antiserum in the kit recogniz es especially the carboxy -terminal end of the osteocalcin molecule, and it binds 50-60% of the amount of labeled osteocalcin. Serum transthyretin, a sensitive marker of protein -energy status, was measured by electroi mmunoassay (7). a-I acid glycoprote in, an acute-phase reactant protein, was measured by radial immunodiffusion (7). In addition , for the most stunted children the following parameters were measured compared with CD children. Total and free triiodothyronine and total thyroxine were determined by using RIA kits (Kodak Diagnostics, Les Ulis, France) . iPTH concentrations were measured using an RIA kit (Nichols Institute Diagnostics, San Juan Capistrano, CA). Serum 1,25(OH)2D and 25(OH)D were measured by competitive binding protein assay (8, 9) .
Statistical analysis was performed using Systat computer program 5.01 (Evanston, IL). Differences between groups were determined using analysis of variance followed by Dunnett's pairwise comparisons test where appropriate. The relationships between serum osteocalcin concentration and other parameters were analyzed by Pearson's linear correlation test and multivariate regression analysis . A p value less than 0.05 was considered significant, and results were expressed as mean ± SEM. Table 2 shows that serum osteocalcin concentrations were low (-46%) in control children living in Dakar compared with those from Paris. Serum osteocalcin concentrations were even significantly lower in stunted (MS and SS) and in severely malnourished (M and K) groups compared with the CD group . Serum transthyretin concentrations were significantl y decreased in hospitalized children (M and K). In contra st, serum a-I acid glycoprotein concentrations were significantly increased in hospitalized children (M and K) compared with the CD group .
RESULTS
In the M group , serum osteocalcin was correlated with weight for age (r = -0.67, p < 0.009, n = 14) and height for age (r = -0.54, p < 0.047, n = 14). However, multiple regression analysis shows that, when weight for age was held constant, serum osteocalcin was not correlated to height for age. Likewise, when considering only control children with weight for height and height for age above -1 Z score (CD and CP), serum osteocalcin was not correlated with anthropometric parameters. Table 3 shows parameters determined in M and in CD children living in Dakar. Serum iPTH, 1,25(OH)2D, and 25(OH)D concentrations were not affected in the maras mic group compa red with CD control group. In contrast thyroid hormones (total triiodothyronine, total thyroxine, and free triiodothyronine) concentrations were significantly decreased in the marasmic group . When Pearson 's correlation test was performed within any of the groups , and serum osteocalcin and transthyretin were correlated in the CD group (r = 0.58, p < 0.015, n = 17), and in the M group (r = 0.78, p < 0.001, n = 14). However, in the M group, multiple regression analysis shows that, when trans- thyretin was held constant, the correlation between osteocalcin and weight for age became insignificant.
DISCUSSION
This study shows that serum osteocalcin concentrations were dramatically reduced in children suffering from severe malnutrition. These results are in accordance with previous findings of depressed bone formation in PEM (10). Thus, taking into account the reduction of bone resorption in Jamaican malnourished children (2), it is suggested that osteopenia in PEM may be of low bone turnover type, with coupled bone formation and resorption.
Recently, the Delmas's team (11) using a battery of MAb have characterized the various immunoreactive forms of circulating osteocalcin in normal adult serum. The intact 49-amino acid molecule represents only 36% of the total immunoreactivity, and the remaining 64% are constituted by osteocalcin fragments. But interestingly this pattern of fragment distribution is similar in both osteoporotic and pagetic patients, suggesting that the fragmentation results from serum enzymatic degradation, rather than from being released from bone matrix during resorption (12, 13) . However, we do not know to what extent the osteocalcin resorbed from the bone matrix could contribute to the reduced circulating levels of osteocalcin in malnutrition. It is widely acknowledged that serum osteocalcin is increased in case of renal failure (14), therefore the low serum osteocalcin is not attributable to the reduction of the GFR that is found during malnutrition (15) .
The low serum osteocalcin levels in stunted children are also in accordance with previous findings (16) . However, although both the control groups have the same anthropometric values, the serum osteocalcin levels were 46% lower in Dakar compared with Paris. These data do not support a direct relationship between growth and serum osteocalcin levels. It is noteworthy that serum osteocalcin values observed in black African children living in Paris (CP) were similar to those of normal French children (16) . The difference in osteocalcin concentration observed between control children living in Paris and Dakar may be a seasonal effect, i.e. the influence of sunlight (17) . But it is difficult to take into account the possible seasonal effect on the osteocalcin level inasmuch as 1) it is not only related to the influence of sunlight, but to the sun exposure habits; 2) there is seasonal variation in France, but this is not the case in Senegal; and 3) conflicting data have been published about the seasonal rhythm of serum osteocalcin (17) . However, a frequent finding in the literature is that serum osteocalcin is low in black subjects (18) . In a recent study, Perry et al. (19) have found also a concomitant low serum albumin and normal 25(OH)D concentrations in older AfricanAmericans, suggesting a poor protein-energy status that could be related to their low serum osteocalcin. It is known that serum osteocalcin is lower in female than in male subjects (17, 20) . The higher proportion of female subjects in the CD group than in the CP group could contribute to the decrease of the mean serum osteocalcin level found in the CD group. However, when considering only the male subjects, their serum osteocalcin level mean value was 3.74 ± 0.30 nmol/L in the CP group and 2.09 ± 0.23 nmol/L in the CD group. Furthermore, in the CD group, serum osteocalcin concentrations of girls were no different from those of boys (1.87 ± 0.49 nmol/L versus 2.09 ± 0.23 nmol/L). Then, these results suggest that the low serum osteocalcin concentrations found in Dakar's children were not related to a racial factor or sex distribution but could be related to environmental constraints.
At least the high prevalence of infections and poor nutritional intakes in this area might be involved in the observed low levels of serum osteocalcin. Indeed, when considering the threshold of 30 lLmol/L for (X-I acid glycoprotein, it is noteworthy that most of the children living in Dakar were seen to be inflamed and/or infected. However, a comparison between eight infected and nine noninfected children of the CD group did not show any difference in serum osteocalcin (1.94 ± 0.42 versus 2.06 ± 0.26 nmol/L, respectively). These results are in accordance with our previous finding showing that, in rats, serum osteocalcin is not affected by experimental inflammation (21) . Therefore, these studies suggest that the low serum osteocalcin concentrations found in malnourished children were independent of inflammatory status.
In M and K, serum osteocalcin and transthyretin levels were deeply decreased on admission to the hospital. In K, 3 wk of nutritional rehabilitation produced a significant rise in both of these proteins (6), suggesting that serum osteocalcin level is sensitive to nutritional status. This is strengthened by the low osteocalcin levels found in patients suffering from anorexia nervosa (22) , in 3-day starved rats (21), or after 4 wk of dietary restriction in rats (23) , whereas high osteocalcin levels are found in obese children fed an energy-rich diet (24) . Michaelsen et al. (25) have found a positive correlation between serum osteocalcin and milk intake in a study of 2-to 9-mo-old breast-fed babies. Serum osteocalcin levels were raised in these breast-fed babies compared with age-matched formula-fed babies (25) . In Senegal, a recent national demographic and health surveys (26) have shown that 98% of babies are breast-fed at 9 mo, 85.3% are breast fed at 17 mo, but only 38.5% still breast fed at 24 mo. The mean duration of breastfeeding is 20.1 mo in Senegal. Considering these results and the fact that the mean ages of our different groups of children are not so different, the decrease of serum osteocalcin in MS, SS, M, and K groups cannot be ascribed to the pratice of breast feeding . Furthermore, the findings of Michaelsen et al. (25) are not in accordance with our study, because when considering that serum osteocalcin levels decreased with age and assuming that breast-feeding is more frequent in Dakar than Paris, we found that serum osteocalcin levels are lower in the CD group (mean age = 13.83 ± 0.92 mo) compared with the CP group (mean age = 15.44 ± 2.29 mo). In our study, it is difficult to distinguish the effects of breast-feeding and age on serum osteocalcin, therefore the effect of breast-feeding on serum osteocalcin needs to be further investigated .
There was no vitamin D deficiency in marasmic and control children living in Dakar, as showed by high levels of serum 25(OH)D, the storage form of vitamin D. Likewise, serum 1,25(OH)2D, the active metabolite of vitamin D, was no different in marasmic children compared with control children living in Dakar, suggesting that their very low serum osteocalcin levels were not attributable to levels of serum 1,25(OH)2D . Indeed, we have found in 3-day starved rats a significant decrease in serum osteocalcin without any change in the concentration of serum 1,25(OH)2D (21) . Serum iPTH, another potential regulator of osteocalcin production (27) , cannot explain a low serum osteocalcin level in PEM, because iPTH concentrations were similar in marasmic and CD control groups. In contrast, thyroid hormone concentrations, which were significantly decreased in marasmic children, could be involved in the decrease of serum osteocalcin. Indeed, hyperthyroidism is often associated with elevated serum osteocalcin levels, whereas low serum osteocalcin levels are found in hypothyroidism (28) . Furthermore , in vivo or in vitro studies have disclosed an increase in osteocalcin synthesis after treatment with physiologic amounts of thyroid hormones (29, 30) . However, osteocalcin synthesis may be decreased by other unmeasured factors, such as low insulin-like growth factor I (31) and high cortisol levels (32) , that are frequently found in malnourished children (33) . Cortisol levels that were higher in K than M (34) may explain the lowest osteocalcin levels found in kwashiorkor. However, there are conflicting data in the literature. Vashi and Jagatiani (35) found no difference in serum cortisol levels between marasmus and kwashiorkor , whereas others (36, 37) found that the cortisol level is more elevated in marasmus than kwashiorkor. Thus, the lowest serum osteocalcin levels found in K remain unclear.
In summary, very low levels of serum osteocalcin were found in stunted and malnourished Senegalese children. The data suggest that serum osteocalcin is related to protein-energy status assessed by serum transthyretin. This is in accordance with previous data obtained in food-restricted rats. The low levels of serum osteocalcin observed in control children living in Dakar suggest that they were not in optimal nutritional status (7) and that bone formation could be altered not only in the malnourished but also in those considered as anthropometrically normal. We suggest that serum osteocalcin could be a new useful tool in the study of bone formation during malnutrition. The serum osteocalcin concentration is widely used in many different clinical settings, including those involving bone, kidney, and liver diseases. It is suggested that these studies should include an assessment of the nutritional status before interpreting the changes in serum osteocalcin concentration.
